619 total citations 43 papers, 512 citations indexed
About
Bodey Gp is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Bodey Gp has authored 43 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Epidemiology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bodey Gp's work include Neutropenia and Cancer Infections (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Antifungal resistance and susceptibility (5 papers). Bodey Gp is often cited by papers focused on Neutropenia and Cancer Infections (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Antifungal resistance and susceptibility (5 papers). Bodey Gp collaborates with scholars based in United States. Bodey Gp's co-authors include Rodríguez, Burgess Ma, Manuel Valdivieso, Fernando Cabanillas, Jean Latreille, KB McCredie, Alfred Distefano, B Rosenbaum, Frank C. Schell and Benjamin Lichtiger and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).
In The Last Decade
Bodey Gp
40 papers
receiving
453 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Bodey Gp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bodey Gp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bodey Gp more than expected).
This network shows the impact of papers produced by Bodey Gp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bodey Gp. The network helps show where Bodey Gp may publish in the future.
Co-authorship network of co-authors of Bodey Gp
This figure shows the co-authorship network connecting the top 25 collaborators of Bodey Gp.
A scholar is included among the top collaborators of Bodey Gp based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Bodey Gp. Bodey Gp is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Drewinko, Benjamin, et al.. (1986). Peplomycin and bleomycin effects on human colon cancer cells.. PubMed. 6(1). 1–3.1 indexed citations
2.
Gp, Bodey, et al.. (1986). Aztreonam: therapy for infections in cancer patients.. PubMed. Spec No. 37–41.1 indexed citations
3.
Dt, Carr, et al.. (1986). Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinoma.. PubMed. 70(6). 795–6.7 indexed citations
4.
Spitzer, Gary, S S Legha, L Vellekoop, et al.. (1982). High-dose AMSA and bone marrow rescue in patients with solid tumors.. PubMed. 66(2). 385–6.9 indexed citations
5.
Murphy, William K., et al.. (1981). Neocarzinostatin: report of a phase II clinical trial.. PubMed. 65(7-8). 699–701.7 indexed citations
6.
Schell, Frank C., et al.. (1981). Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer.. PubMed. 65(5-6). 465–7.7 indexed citations
Cabanillas, Fernando, Rodríguez, & Bodey Gp. (1980). Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphoma.. PubMed. 64(8-9). 933–7.14 indexed citations
9.
Latreille, Jean, et al.. (1980). Neurologic and cardiac rhythm abnormalities associated with 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) therapy.. PubMed. 63(11-12). 2001–3.20 indexed citations
10.
Ma, Burgess, et al.. (1980). Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.. PubMed. 3(2). 111–4.7 indexed citations
11.
Distefano, Alfred, et al.. (1979). Phase II study of anguidine in advanced breast cancer.. PubMed. 63(5). 789–91.18 indexed citations
12.
Js, Hewlett, et al.. (1979). Combination 6-mercaptopurine and 6-methylmercaptopurine riboside in the treatment of adult acute leukemia: a Southwest Oncology Group study.. PubMed. 63(1). 156–8.8 indexed citations
13.
Valdivieso, Manuel, et al.. (1978). Chemotherapy for adenocarcinoma and large cell anaplastic carcinoma of the lung with ftorafur, adriamycin, and cis-dichlorodiammineplatinum(II).. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(7). 1089–91.9 indexed citations
14.
Gp, Bodey & Rodríguez. (1978). Approaches to the treatment of acute leukemia and lymphoma in adults.. PubMed. 15(3). 221–61.33 indexed citations
15.
Gp, Bodey, et al.. (1977). Gram-negative bacillary infections in cancer patients.. PubMed. 52(26). 1049–55.2 indexed citations
16.
Ma, Burgess, et al.. (1977). Phase I-II evaluation of cyclocytidine.. PubMed. 61(3). 437–43.8 indexed citations
17.
Gp, Bodey. (1975). Infections in cancer patients. II. Fungal infections.. PubMed. 7(5-6). 567–72.
18.
Gp, Bodey, et al.. (1972). Pneumocystis carinii pneumonitis in cancer patients.. PubMed. 30(1). 41–56.13 indexed citations
19.
Gp, Bodey, et al.. (1969). Therapy of infections with the combination of carbenicillin and gentamicin.. PubMed. 9. 386–90.34 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.